Superstores H-Medix and Max Health are locked in a multi-million-naira legal dispute involving the Federal Competition and Consumer Protection Commission (FCCPC).
The case is over alleged monopoly practices and the legality of H-Medix’s expansion across Abuja, Nigeria’s capital.
The Federal High Court in Abuja has fixed January 12, 2026, for the hearing of all case documents filed by Max Health.
The company is seeking a court injunction against the Pharmacy Council of Nigeria (PCN) for approving multiple outlets for H-Medix.
Max Health alleges that H-Medix has received preferential regulatory treatment. This allows it to dominate the pharmaceutical market in Abuja to the detriment of smaller competitors.
The FCCPC, PCN, Federal Capital Territory Administration (FCTA), and Pharmaceutical Society of Nigeria (PSN) are among the named defendants.
In its claim, Max Health accused H-Medix of operating more than 11 mega outlets in Abuja. This is despite regulatory restrictions on monopoly and unfair competition. The company’s counsel, F.D. Ayinde, said the retail chain distorts the market. It combines pharmacy services with grocery, bakery, and household sections, driving competitors out of business.
ALSO READ
Max Health further asked the court to compel the FCCPC to conduct a full monopoly investigation into H-Medix’s business operations under the FCCPC Act.
Responding through its counsel, Fredrick Itula (SAN), H-Medix denied any wrongdoing. The company stated that its business fully complies with all regulatory standards. Its outlets are routinely inspected and licensed by the PCN.
The company argued it employs over 100 licensed pharmacists—above regulatory minimums. Several other pharmacies also operate within close proximity to its branches, refuting the monopoly claim. H-Medix also filed a counterclaim seeking N150 million in damages. They are asking for a public apology from Max Health for reputational harm.
The FCCPC, in its defense, said it is already investigating the monopoly allegations. However, it asked the court to dismiss the case for lack of jurisdiction. They argue Max Health filed prematurely before the agency concluded its probe.
Justice Obiora Egwatu adjourned the matter to January 12, 2026, for hearing.
